ACELRX PHARMACEUTICALS INC (ACRX) Stock Analyst Ratings
NASDAQ:ACRX - Nasdaq - US00444T2096 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to ACRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.72. This target is 448.55% above the current price.
ACRX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ACRX.
In the previous month the buy percentage consensus was at a similar level.
ACRX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-02 | Alliance Global Partners | Initiate | Buy |
| 2023-09-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-18 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2021-08-17 | HC Wainwright & Co. | Maintains | Buy |